The abstract is read at the publisher; the summary is JClub's.
EphA4 shapes head and neck squamous cell carcinoma outcomes by cell-type–specific negative regulation of AKT, with EphA4 loss increasing AKT activation and altering Treg, macrophage, CD8, and cancer-cell behaviors.
- Why it matters: HNSCC is supported by an immunosuppressive tumor microenvironment, and the field lacks clear, cell-type–resolved mechanisms linking EphA4 to immune dysfunction and tumor growth.
- What they did: The study combined spatial analysis, multicompartment RNA sequencing in oral cavity squamous cell carcinoma, and three genetically engineered mouse models, then tested EphA4 inhibition with APY-d3-PEG4 and assessed AKT signaling changes.
- The result: EphA4 in Tregs promoted tumor growth, while EphA4 in myeloid cells, CD8+ T cells, and cancer cells limited it; EphA4 knockout increased AKT activation, reducing Treg immunosuppression, shifting macrophages toward M2, impairing CD8 memory differentiation, and enhancing cancer proliferation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.